000281641 001__ 281641
000281641 005__ 20251103102758.0
000281641 0247_ $$2doi$$a10.1212/NXI.0000000000200489
000281641 0247_ $$2pmid$$apmid:41061181
000281641 037__ $$aDZNE-2025-01159
000281641 041__ $$aEnglish
000281641 082__ $$a610
000281641 1001_ $$00000-0003-4906-5983$$aOertel, Frederike Cosima$$b0
000281641 245__ $$aAPOSTEL-R Recommendations for Reporting Retinal Optical Coherence Tomography Studies in Rodents.
000281641 260__ $$aPhiladelphia, Pa.$$bWolters Kluwer$$c2025
000281641 3367_ $$2DRIVER$$aarticle
000281641 3367_ $$2DataCite$$aOutput Types/Journal article
000281641 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762161498_20021
000281641 3367_ $$2BibTeX$$aARTICLE
000281641 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281641 3367_ $$00$$2EndNote$$aJournal Article
000281641 520__ $$aRetinal optical coherence tomography (OCT) in rodent models has been used to longitudinally image retinal changes, to define end points for more costly or time-consuming experiments, and to better understand the pathophysiology underlying OCT findings in human diseases. No standardization of rodent OCT reporting currently exists. Here, we aim to establish consensus recommendation for reporting results from retinal OCT studies in rodents.Initial recommendations were developed based on the APOSTEL criteria for quantitative OCT reporting in humans by a core team. Using a modified Delphi process, an expert panel of rodent OCT researchers (N = 31) and the wider scientific community discussed, refined, and voted on these initial recommendations. The list of recommendations was then revised and approved by the expert panel.The final 7-point checklist includes reporting recommendations regarding the study protocol, OCT device, acquisition settings and modifications, scanning protocol, funduscopic imaging, postacquisition data selection and image data analyses, and qualitative and quantitative results. With a median agreement score of 3 or 4 out of 4, the scientific community agreed with these recommendations. After revisions, the expert panel accepted the final recommendations.The Advised Protocol for OCT Study Terminology and Elements for reporting OCT studies in rodents (APOSTEL-R) originates from an expert consensus. They will provide guidance throughout the experimental process and will contribute to the standardization and quality improvement of preclinical OCT studies.
000281641 536__ $$0G:(DE-HGF)POF4-351$$a351 - Brain Function (POF4-351)$$cPOF4-351$$fPOF IV$$x0
000281641 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281641 650_2 $$2MeSH$$aTomography, Optical Coherence: standards
000281641 650_2 $$2MeSH$$aTomography, Optical Coherence: methods
000281641 650_2 $$2MeSH$$aAnimals
000281641 650_2 $$2MeSH$$aRetina: diagnostic imaging
000281641 650_2 $$2MeSH$$aRodentia
000281641 650_2 $$2MeSH$$aRats
000281641 650_2 $$2MeSH$$aConsensus
000281641 7001_ $$aCabrera Debuc, Delia$$b1
000281641 7001_ $$00000-0002-7776-6472$$aCalabresi, Peter A$$b2
000281641 7001_ $$00000-0001-5661-1386$$aChen, Mei$$b3
000281641 7001_ $$00000-0002-1413-0442$$aCordano, Christian$$b4
000281641 7001_ $$aDietrich, Michael$$b5
000281641 7001_ $$aFeltgen, Nicolas$$b6
000281641 7001_ $$00000-0001-6948-0522$$aGramlich, Oliver$$b7
000281641 7001_ $$00000-0001-9275-3066$$aGreen, Ari J$$b8
000281641 7001_ $$0P:(DE-2719)9002589$$aGroh, Janos$$b9
000281641 7001_ $$00000-0002-7359-6736$$aHuang, Su-Chun$$b10
000281641 7001_ $$00000-0003-4187-9472$$aKnier, Benjamin$$b11
000281641 7001_ $$00000-0002-3633-0955$$aKorn, Thomas$$b12
000281641 7001_ $$00000-0001-9326-6753$$aLeocani, Letizia$$b13
000281641 7001_ $$aLoewenstein, Anat$$b14
000281641 7001_ $$avan Oterendorp, Christian$$b15
000281641 7001_ $$aPeto, Tunde$$b16
000281641 7001_ $$aSchippling, Sven$$b17
000281641 7001_ $$aSchmetterer, Leopold$$b18
000281641 7001_ $$aSchmitz-Valckenberg, Steffen$$b19
000281641 7001_ $$00000-0002-7879-6788$$aSeeliger, Mathias W$$b20
000281641 7001_ $$00000-0003-2417-258X$$aShindler, Kenneth S$$b21
000281641 7001_ $$00000-0002-8885-3766$$aSchuman, Joel S$$b22
000281641 7001_ $$00009-0008-2890-2336$$aSindi, Mustafa$$b23
000281641 7001_ $$aTufail, Adnan$$b24
000281641 7001_ $$00000-0001-8308-8455$$aWang, Jui-Kai$$b25
000281641 7001_ $$00000-0002-7467-7028$$aWolf, Sebastian$$b26
000281641 7001_ $$00000-0002-0175-3018$$aYou, Yuyi$$b27
000281641 7001_ $$aZinkernagel, Martin$$b28
000281641 7001_ $$00000-0002-3558-5905$$aLagrèze, Wolf$$b29
000281641 7001_ $$00000-0001-7987-658X$$aAlbrecht, Philipp$$b30
000281641 7001_ $$aconsortium, IMSVISUAL$$b31$$eCollaboration Author
000281641 773__ $$0PERI:(DE-600)2767740-0$$a10.1212/NXI.0000000000200489$$gVol. 12, no. 6, p. e200489$$n6$$pe200489$$tNeurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology$$v12$$x2332-7812$$y2025
000281641 8564_ $$uhttps://pub.dzne.de/record/281641/files/DZNE-2025-01159.pdf$$yOpenAccess
000281641 8564_ $$uhttps://pub.dzne.de/record/281641/files/DZNE-2025-01159.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000281641 909CO $$ooai:pub.dzne.de:281641$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000281641 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002589$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000281641 9131_ $$0G:(DE-HGF)POF4-351$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vBrain Function$$x0
000281641 9141_ $$y2025
000281641 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-27
000281641 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000281641 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROL-NEUROIMMUNOL : 2022$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-13T18:57:06Z
000281641 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-13T18:57:06Z
000281641 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281641 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2021-02-13T18:57:06Z
000281641 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROL-NEUROIMMUNOL : 2022$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-27
000281641 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-27
000281641 9201_ $$0I:(DE-2719)1110008$$kAG Simons$$lMolecular Neurobiology$$x0
000281641 980__ $$ajournal
000281641 980__ $$aVDB
000281641 980__ $$aUNRESTRICTED
000281641 980__ $$aI:(DE-2719)1110008
000281641 9801_ $$aFullTexts